---
title: Certara vs Oncodesign Services
slug_a: certara
slug_b: oncodesign-services
site: cro
review_signal_gate: closed
canonical_path: /compare/certara/oncodesign-services
generated_by: BioBM Editorial AI
---

# Certara vs Oncodesign Services

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Certara (certara) is listed for cro. Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making.

Services: 37. Modalities: 20. Indications: 25. Locations: 8. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (37).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Oncodesign Services (oncodesign-services) is listed for cro. Contract research organization specializing in drug discovery and preclinical services for oncology, inflammation, and infectious diseases since 1995.

Services: 31. Modalities: 4. Indications: 9. Locations: 2. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (31).

Review summary: Review summary withheld until site-level review gate opens.